Centene (CNC) Stock Forecast & Price Target

Centene is supported by a large, diversified managed-care franchise serving about 20 million members, with roughly 64% in Medicaid, 28% in the individual exchanges, and 5% in Medicare, giving it scale and deep state relationships that strengthen its competitive moat. The outlook is constructive because 3Q26 showed Medicaid cost trend stabilizing, MA reaching breakeven a year early, and Marketplace margins moving to the top of their range, while management guided to margin improvement across most of the portfolio off roughly 1% Medicaid margins, 5% Marketplace margins, breakeven MA, and mid-to-high 3s PDP margins. Financially, management raised 2026 adjusted EPS guidance to above $3.40 from above $3.00, and the company expects earnings to build on the $4.70 jumping-off point as rate catch-up, a healthier risk pool, PDP growth, and lower SG&A support a multi-year recovery.

Centene is facing deteriorating fundamentals as OBBBA reduces federal Medicaid support by about $910B over the next decade, while work requirements beginning in 2027 and more frequent redeterminations threaten membership, pricing power, and state reimbursement adequacy. Its operating performance has already weakened, with 2025 ending at roughly a -1% pre-tax margin versus a 5% to 7.5% target, a $6.7B goodwill impairment, and elevated medical cost trends in Medicaid, Medicare Advantage, and the exchanges. The outlook remains negative because management expects Medicaid membership to fall about 6% from year-end 2025 to year-end 2026, while persistent behavioral health, high-cost drug, and risk-adjustment volatility continue to pressure earnings.